GLOW THERAPEUTICS INC.

Biotech · Private

Light-activatable nanoplatform for intraperitoneal photodynamic therapy and chemotherapy co-delivery to treat peritoneal metastasis

Grants
$305K
1 award
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantNational Science Foundation · Phase I · SBIR Phase I: The TPMAL Platform for Targeted Delivery of Photodynamic Therapy and Chemotherapy to Peritoneal Metastasis$305,000
Federal grant · SBIR/STTR

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2981QUORUM INNOVATIONS, LLC——
2982NuPeak Therapeutics, Inc.——
2983SINGULAR IMMUNE, INC.——
2984GLOW THERAPEUTICS INC.——
2985TIGATX INC——
2986Whisper Biosciences——
2987Singular Genomics——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.